Swiss National Bank boosted its stake in Xylem Inc. (NYSE:XYL – Free Report) by 7.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 714,592 shares of the industrial products company’s stock after purchasing an additional 47,500 shares during the quarter. Swiss National Bank’s holdings in Xylem were worth $85,394,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. J. Stern & Co. LLP raised its position in shares of Xylem by 12,326.6% in the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after acquiring an additional 45,082,435 shares during the period. Norges Bank bought a new position in Xylem during the 4th quarter worth approximately $361,012,000. Balyasny Asset Management L.P. grew its holdings in Xylem by 346.2% during the third quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock valued at $105,160,000 after purchasing an additional 553,152 shares during the period. Adage Capital Partners GP L.L.C. acquired a new position in Xylem during the second quarter valued at approximately $64,407,000. Finally, SG Americas Securities LLC increased its stake in Xylem by 255.4% in the first quarter. SG Americas Securities LLC now owns 681,904 shares of the industrial products company’s stock valued at $81,488,000 after purchasing an additional 490,040 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.
Insiders Place Their Bets
In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at approximately $423,443.30. The trade was a 54.22% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jerome A. Peribere purchased 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The shares were acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.32% of the stock is currently owned by company insiders.
Xylem Trading Down 1.6%
Xylem (NYSE:XYL – Get Free Report) last issued its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company had revenue of $2.12 billion during the quarter, compared to analysts’ expectations of $2.11 billion. During the same period last year, the business earned $1.03 EPS. The business’s quarterly revenue was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.
Xylem Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were given a $0.43 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. Xylem’s dividend payout ratio (DPR) is 42.79%.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on XYL shares. Barclays cut their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a report on Wednesday, April 29th. Stifel Nicolaus lowered their price objective on shares of Xylem from $159.00 to $157.00 and set a “buy” rating for the company in a research report on Monday. Weiss Ratings downgraded Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Jefferies Financial Group upgraded Xylem from a “hold” rating to a “buy” rating and lifted their target price for the stock from $130.00 to $140.00 in a report on Thursday, June 25th. Finally, UBS Group boosted their target price on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $153.15.
View Our Latest Stock Report on Xylem
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Articles
- Five stocks we like better than Xylem
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
